Rheumatoid arthritis trials in France

In France 49 Also abroad 351

49 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in France
Small Airway Dysfunction in Rheumatoid Arthritis and Systemic Sclerosis
Where
Paris
Age
18 years and over
People
184
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07924124
Phase 1/2Not yet taking people in France
Phase 1/2 study to evaluate the safety, pharmacokinetics, and preliminary efficacy of SAR447998 in adults with refractory Systemic Lupus Erythematosus or Rheumatoid Arthritis
Where
Marseille, Montpellier Cedex 5, Pessac
Age
18 years and over
People
10
Run by
Sanofi-Aventis Recherche & Developpement
See details and how to join2026-526117-28-00 · EU 2026-526117-28-00
Phase 2Not yet taking people in France
Functional Imaging of Digital Osteoarthritis and Rheumatoid Arthritis Using 99mTc-NTP 15-5 in Nuclear Medicine
Where
Clermont-Ferrand
Age
18 years and over
People
80
Run by
Centre Jean Perrin
See details and how to joinNCT07624994
Phase 1Taking people
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Where
Bordeaux, Montpellier, Nancy, Paris, Strasbourg Cedex 2, Toulouse Cedex 9
Age
18 years to 70 years
People
72 worldwide
Run by
AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Where
Marseille, Montpellier, Paris, Strasbourg, Toulouse
Age
18 years and over
People
160 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07137598
Phase 2Taking people
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Where
Marseille, Montpellier Cedex 5, Paris, Strasbourg Cedex 2, Toulouse
Age
18 years and over
People
120 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07620392 · EU 2025-523579-47-00
Phase 1Not yet taking people in France
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Where
Montpellier, Paris
Age
18 years and over
People
60 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07873931
Phase 2Taking people
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Where
Le Kremlin-Bicêtre, Lille, Lyon, Lyon Cédex 3, Marseille, Paris, Strasbourg, Toulouse
Age
18 years to 75 years
People
220 worldwide
Run by
Amgen
See details and how to joinNCT06570798
No phaseTaking people
National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis
Where
Montpellier
Age
18 years to 80 years
People
150
Run by
University Hospital, Montpellier
See details and how to joinNCT06876064
No phaseTaking people
Exactech Shoulder Post Market Clinical Follow-up Study
Where
Grenoble, Mérignac, Rennes
Age
21 years and over
People
20,000 worldwide
Run by
Exactech
See details and how to joinNCT05603728
Phase 2Taking people
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
Where
Marseille, Montpellier Cedex 5, Paris, Strasbourg Cedex 2, Toulouse
Age
18 years and over
People
89 worldwide
Run by
F. Hoffmann-La Roche AG
See details and how to join2025-521034-28-00 · EU 2025-521034-28-00
Phase 1Not yet taking people in France
Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
Where
Villejuif
Age
18 years to 75 years
People
6
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07544225
Phase 1Taking people
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
Where
Montpellier, Strasbourg Cedex 2
Age
18 years to 75 years
People
36 worldwide
Run by
AbbVie
See details and how to joinNCT06977724 · EU 2024-519157-10-00
Phase 4Taking people
JAK Inhibitor Dose TAPering Strategy Study
Where
Amiens Cedex 1, Bordeaux, Brest Cedex 2, Chambray Les Tours, Clermont Ferrand Cedex 1, Le Kremlin-Bicetre, Le Mans Cedex 9, Limoges, Lomme Cedex, Marseille, Montpellier Cedex 5, Nice, Orleans Cedex 2, Paris, Paris Cedex 10, Paris Cedex 13, Paris Cedex 14, Reims, Rouen Cedex, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Toulouse, Vandoeuvre Les Nancy Cedex
Age
18 years to 65 years
People
308
Run by
University Hospital, Toulouse
See details and how to joinNCT06687551 · EU 2023-509788-25-00
Phase 2Taking people
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Where
Marseille, Montpellier, Toulouse Cedex 9
Age
18 years and over
People
90 worldwide
Run by
Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00
Phase 2Not yet taking people in France
functional imaging of digital osteoarthritis and rheumatoid arthritis using 99mTc-NTP15-5 in nuclear medicine : phase II clinical study
Where
Clermont-Ferrand
Age
18 years and over
People
80
Run by
Centre Jean Perrin
See details and how to join2025-523650-14-00 · EU 2025-523650-14-00
Phase 1Taking people
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Where
Lille Cedex, Strasbourg Cedex 2
Age
18 years and over
People
125 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00
No phaseTaking people
Clinical Outcomes Study of the Nexel Total Elbow
Where
Toulouse
Age
18 years and over
People
134 worldwide
Run by
Zimmer Biomet
See details and how to joinNCT02469662
No phaseTaking people
Immun4Cure Cohort of Autoimmune Diseases
Where
Montpellier
Age
18 years and over
People
500
Run by
University Hospital, Montpellier
See details and how to joinNCT07515638
No phaseTaking people
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU
Where
Brest
Age
18 years and over
People
300
Run by
University Hospital, Brest
See details and how to joinNCT06551389
No phaseTaking people
"Translating Articular Biomarkers Into Diagnoses"
Where
Paris
Age
18 years and over
People
50
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06312943
Phase 1Taking people
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Where
Bordeaux, Toulouse Cedex 9
Age
18 years to 70 years
People
44 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00
No phaseTaking people
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Where
Paris
Age
18 years and over
People
5,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07077304
No phaseTaking people
Insole Optimization for Rheumatoid Arthritis Patients
Where
Saint-Etienne
Age
18 years and over
People
10
Run by
Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT07321340
Phase 4Not yet taking people in France
Tdose Binding and Tocilizumab
Where
Marseille, Nice
Age
18 years and over
People
122
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07582185 · EU 2025-522319-41-00